Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical. efflux transporters in Caco-2 cell monolayers

被引:158
作者
Collnot, EM
Baldes, C
Wempe, MF
Hyatt, J
Navarro, L
Edgar, KJ
Schaefer, UF
Lehr, CM [1 ]
机构
[1] Univ Saarland, Dept Biopharmaceut & Pharmaceut Technol, D-66123 Saarbrucken, Germany
[2] Eastman Chem Co, Kingsport, TN 37662 USA
关键词
P-glycoprotein; vitamin E TPGS; absorption enhancer; poly(ethylene glycol); Caco-2;
D O I
10.1016/j.jconrel.2005.11.005
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
(D)-alpha-tocopheryl poly(ethylene glycol) 1000 succinate (TPGS 1000) is a widely used form of vitamin E. TPGS 1000 is comprised of a hydrophilic polar (water-soluble) head and a lipophilic (water-insoluble) alkyl tail. TPGS 1000 has been used as a solubilizer, an emulsifier and as a vehicle for lipid-based drug delivery formulations. Most recently, TPGS 1000 has been recognized as an effective oral absorption enhancer. An enhancing effect is consistent with a surfactant-induced inhibition of P-glycoprotein (P-gp), and perhaps other drug transporter proteins; however, the exact inhibition mechanism(s) remain unclear. Therefore, in an attempt to generate additional knowledge, we have synthesized and tested various TPGS analogs containing different PEG chain length (TPGS 200/238/400/600/1000/2000/3400/3500/4000/6000). These results demonstrate a relationship between TPGS PEG chain length and influence on rhodamine 123 (RHO) transport in Caco-2 monolayers, a relationship which may be illustrated using a Weibull distribution. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 41 条
[1]   Intestinal membrane transport of drugs and nutrients:: genomics of membrane transporters using expression microarrays [J].
Anderle, P ;
Huang, Y ;
Sadée, W .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 21 (01) :17-24
[2]   The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins [J].
Bogman, K ;
Erne-Brand, F ;
Alsenz, J ;
Drewe, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (06) :1250-1261
[3]  
BOUDREAUX JP, 1993, TRANSPLANT P, V25, P1875
[4]   The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability [J].
Chan, LMS ;
Lowes, S ;
Hirst, BH .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 21 (01) :25-51
[5]   Enhanced bioavailability of paclitaxel after oral coadministration with flavone in rats [J].
Choi, JS ;
Choi, HK ;
Shin, SC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 275 (1-2) :165-170
[6]   Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo [J].
Cornaire, G ;
Woodley, J ;
Hermann, P ;
Cloarec, A ;
Arellano, U ;
Houin, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 278 (01) :119-131
[7]  
Dantzig AH, 1996, CANCER RES, V56, P4171
[8]   Inhibition of P-glycoprotein by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) [J].
Dintaman, JM ;
Silverman, JA .
PHARMACEUTICAL RESEARCH, 1999, 16 (10) :1550-1556
[9]   DETECTION OF P-GLYCOPROTEIN ACTIVITY ON NORMAL AND LEUKEMIC CD34+ CELLS [J].
DRENOU, B ;
FARDEL, O ;
AMIOT, L ;
FAUCHET, R .
LEUKEMIA RESEARCH, 1993, 17 (12) :1031-1035
[10]   Importance of P-glycoprotein at blood-tissue barriers [J].
Fromm, MF .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (08) :423-429